MARKET

AXSM

AXSM

Axsome Therapeut
NASDAQ
63.83
-3.02
-4.52%
After Hours: 64.70 +0.87 +1.36% 19:54 10/03 EDT
OPEN
66.59
PREV CLOSE
66.85
HIGH
66.97
LOW
63.67
VOLUME
815.11K
TURNOVER
0
52 WEEK HIGH
91.29
52 WEEK LOW
38.87
MARKET CAP
3.01B
P/E (TTM)
-14.9167
1D
5D
1M
3M
1Y
5Y
Maintaining Buy Rating for Axsome Therapeutics: Steady Auvelity Sales and Anticipated Q3 Performance Insights
TipRanks · 1d ago
Weekly Report: what happened at AXSM last week (0925-0929)?
Weekly Report · 2d ago
Analysts’ Top Healthcare Picks: Axsome Therapeutics (AXSM), Cytokinetics (CYTK)
TipRanks · 09/27 06:32
Analyst Ratings for Axsome Therapeutics
Benzinga · 09/25 19:00
Harmony Bio falls as Goldman Sachs cuts to Sell on revenue risks
Seeking Alpha · 09/25 17:08
Mizuho Reiterates Buy on Axsome Therapeutics, Maintains $100 Price Target
Benzinga · 09/25 15:35
Weekly Report: what happened at AXSM last week (0918-0922)?
Weekly Report · 09/25 11:01
Analysts’ Top Healthcare Picks: Cytokinetics (CYTK), Amgen (AMGN)
TipRanks · 09/25 11:00
More
About AXSM
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is developing and delivering novel therapies for the central nervous system (CNS), conditions that have limited treatment options. The Company's two commercial products and development programs are Auvelity and Sunosi. Auvelity (dextromethorphan-bupropion) is an oral, N-methyl-D-aspartate (NMDA) receptor antagonist with multimodal activity indicated for the treatment of the major depressive disorder (MDD). Sunosi (solriamfetol) is an oral medication indicated for the treatment of excessive daytime sleepiness (EDS), in patients with narcolepsy or obstructive sleep apnea. Its AXS-05 is an oral, investigational NMDA receptor antagonist with multimodal activity for the treatment of Alzheimer's disease agitation (AD agitation) and smoking cessation. Its AXS-07 is a multi-mechanistic, investigational medicine under development for the acute treatment of migraine.

Webull offers kinds of Axsome Therapeutics Inc stock information, including NASDAQ:AXSM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AXSM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AXSM stock methods without spending real money on the virtual paper trading platform.